MeSH tree: C10.574
Research at the University of Missouri could lead to new therapies for people with amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. In a preclinical model, the researchers discovered that tongue exercise ...
Oct 19, 2026
0
10
Alzheimer's disease may not be a single, uniform condition, but a complex disorder shaped by different combinations of cognitive symptoms, brain changes, biology, genetics and risk factors. A team of researchers propose using ...
Oct 19, 2026
0
5
Researchers at the University of Colorado Anschutz have discovered how herpes simplex virus type 1 (HSV-1), the virus that causes cold sores, can fundamentally change how the brain's immune cells respond to infection, revealing ...
Oct 19, 2026
0
65
A three-letter sequence repeating along a stretch of DNA could offer new clues about why some people are more susceptible to Alzheimer's disease than others. The sequence, CCG, sits in a region of DNA that controls the gene ...
A research team led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC), in collaboration with Míriam Royo's laboratory at the Institute for Advanced Chemistry of ...
Oct 17, 2026
0
31
Nuclear medicine is playing an increasingly important role in the diagnosis and treatment of Alzheimer's disease, helping clinicians visualize the biological changes associated with the condition and guide decisions about ...
Oct 16, 2026
0
12
For patients battling neurodegenerative diseases like ALS, Parkinson's, Alzheimer's and other dementias, delivering disease-fighting antibody drugs directly to the brain has proven to be a difficult task. Our bodies set up ...
Oct 16, 2026
0
93
Researchers were able to restore the function of neurons linked to cognitive function and information processing in mice that mimic key features of Alzheimer's disease, showing early promise for the development of a similar ...
Oct 16, 2026
0
16
One of the great challenges in treating diseases like amyotrophic lateral sclerosis (ALS) is not necessarily finding a promising drug. It is getting the drug to the right place.
Oct 15, 2026
0
14
The first disease-modifying drugs for Alzheimer's disease offer patients the ability to slow cognitive decline by targeting amyloid plaques in the brain. But a new study suggests that not all patients have the same opportunity ...
Oct 15, 2026
0
6
